Sunrest Lifescience IPO GMP, price, Details, Date, Allotment 2023

Sunrest Lifescience IPO description – Sunrest Lifescience Limited is coming up with its Initial public offering. The IPO will be open for subscription on November 7, 2023

Sunrest Lifescience IPO – Details

 

IPO Open Date 07 November 2023
IPO Close Date 09 November 2023
Issue Type Fixed Price Issue IPO
Issue Size 12,91,200 Shares Worth ₹10.85 Crore

Fresh Issue: 12,91,200 Shares Worth ₹10.85 Crore

Face Value ₹10 per equity share
IPO Price ₹84
Market Lot 1600 Shares
Min Order 1600 Shares (1 Lot)
Listing At NSE SME
Register Skyline Financial Services Private Ltd
Retail Shares Offered 50%
Other Shares Offered 50%

 

Micropro Software Solutions IPO

Baba Food Processing IPO

mamaearth ipo

ESAF Bank IPO

 

Sunrest Lifescience IPO – Date Schedule

 

IPO Opening Date 07 November 2023
IPO Closing Date 09 November 2023
Finalization of Basis of Allotment 15 November 2023
Refunds Initiation 16 November 2023
Transfer of shares to demat accounts 17 November 2023
IPO Listing Date 20 November 2023

 

Sunrest Lifescience IPO GMP, price, Details, Date, Allotment 2023

 

Sunrest Lifescience IPO- about company 

 

Sunrest Lifescience Limited is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. The company offers a diverse range of healthcare and personal care products.

The company’s product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience’s product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malarial, Anti Diabetic, Dental Cure, Anti Protozoal, AntiHistamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory. The company has 18 Registered Trademarks for 32 products.

The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.

Sunrest Lifescience’s clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.

 

Sunrest Lifescience IPO- industry overview 

 

India’s healthcare industry has been growing at a Compound Annual Growth Rate of around 22% since 2016. At this rate, it is expected to reach USD 372 Billion in 2022. Healthcare has become one of the largest sectors of the Indian economy, in terms of both revenue and employment.

 

Sunrest Lifescience Financial Performance

 

  FY 2021 FY 2022 FY 2023 Q1 FY 2024
Revenue 16.95 26.89 24.64 5.64
Expenses 16.72 25.86 21.93 4.66
Net income 0.17 0.78 2.04 0.75

Figures in INR Crores

Sunrest Lifescience Valuations & Margins

 

FY 2021 FY 2022 FY 2023
EPS 0.55 2.59 6.81
PE ratio 12.33
RONW (%) 56.12 72.49 65.59
NAV 10.38
EBITDA (%) 1.62 4.17 11.89
Debt/Equity 7.72 2.88 0.64

 

Sunrest Lifescience IPO Prospectus

 

 

Sunrest Lifescience IPO -Competitive Strengths

  • Wide range of Products.
  • Experienced Promoters and Management Team.
  • Efficient marketing team.

 

Object Of The Issue

 

  • General Corporate Purposes.
  • Meeting Working Capital Requirements.

Sunrest Lifescience IPO GMP Today

 

 

Date IPO GMP Kostak Subject to Sauda
4 November 2023 10 9,000

 

Sunrest Lifescience IPO Allotment Status

 

Sunrest Lifescience IPO allotment status will be available on the Click on this link to get allotment status.

Sunrest Lifescience IPO – Lots Size & Price

 

Application Lots Shares Amount ( Cut-Off)
Retail (Minimum) 1 1600 1,34,400
Retail (Maximum) 1 1600 1,34,400
HNI (Minimum) 2 3200 2,68,800

 

 

JOIN OUR TELEGRAM

 

Visit IPOBRAIN home page for latest IPO update

Leave a Comment